Hypertension: Renal denervation-promising data from the DENERHTN trial

Nature Reviews. Nephrology
Wen-Yi Yang, Jan A Staessen

Abstract

In patients with resistant hypertension, renal denervation plus standardized stepped-care antihypertensive treatment (SSAHT) resulted in significant blood-pressure lowering compared with SSAHT alone. These new data from the DENERHTN trial may indicate that despite the failure of SYMPLICITY HTN-3, there is light at the end of the tunnel for renal denervation.

References

Feb 26, 2004·JAMA : the Journal of the American Medical Association·Jan A StaessenUNKNOWN Treatment of Hypertension Based on Home or Office Blood Pressure (THOP) Trial Investigators
Feb 10, 2012·JAMA : the Journal of the American Medical Association·Luana Colloca, Damien Finniss
Apr 1, 2014·The New England Journal of Medicine·Deepak L BhattUNKNOWN SYMPLICITY HTN-3 Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.